Cargando…
Pediatric ulcerative colitis: current treatment approaches including role of infliximab
Ulcerative colitis is a chronic inflammatory bowel disease that can lead to derangements in the growth, nutritional status, and psychosocial development of affected children. There are several medical options for the induction and maintenance of disease remission, but the benefits of these medicatio...
Autores principales: | Bradley, Gia M, Oliva-Hemker, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3379853/ https://www.ncbi.nlm.nih.gov/pubmed/22740771 http://dx.doi.org/10.2147/BTT.S31833 |
Ejemplares similares
-
Pediatric Ulcerative Colitis: The Therapeutic Road to Infliximab
por: Puthoor, Pamela R., et al.
Publicado: (2013) -
Infliximab in ulcerative colitis
por: Levin, Avi, et al.
Publicado: (2008) -
Cause for controversy? Infliximab in the treatment of ulcerative colitis: an update
por: Lawlor, Garrett, et al.
Publicado: (2009) -
Early Serum Infliximab Levels in Pediatric Ulcerative Colitis
por: deBruyn, Jennifer C. C., et al.
Publicado: (2021) -
Infliximab: the evidence for its place in therapy in ulcerative colitis
por: Van Assche, Gert, et al.
Publicado: (2007)